Skip to main content
SpringerLink
Log in

Treatment of Mesothelioma with Radiotherapy

  • Chapter
Malignant Mesothelioma

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Hall E. Radiobiology for the Radiologist, 5th ed. Philadelphia: Lippincott Williams & Wilkins, 2000.

    Google Scholar 

  2. Evans S, et al. Detection of hypoxia in human squamous cell carcinoma by EF5 binding. Cancer Res 2000;60:2018–2024.

    PubMed  CAS  Google Scholar 

  3. Evans SM, et al. Hypoxic heterogeneity in human tumors: EF5 binding, vasculature, necrosis, and proliferation. Am J Clin Oncol 2001;24(5):467–472.

    Article  PubMed  CAS  Google Scholar 

  4. Brizel DM, et al. Oxygenation of head and neck cancer: changes during radiotherapy and impact on treatment outcome. Radiother Oncol 1999;53(2):113–117.

    Article  PubMed  CAS  Google Scholar 

  5. Intensity-modulated radiotherapy: current status and issues of interest. Int J Radiat Oncol Biol Phys 2001;51(4):880–914.

    Google Scholar 

  6. Zelefsky MJ, et al. High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer. J Urol 2001;166(3):876–881.

    Article  PubMed  CAS  Google Scholar 

  7. Eisbruch A, et al. Intensity-modulated radiation therapy for head and neck cancer: emphasis on the selection and delineation of the targets. Semin Radiat Oncol 2002;12(3):238–249.

    Article  PubMed  Google Scholar 

  8. Glatstein E. Intensity-modulated radiation therapy: the inverse, the converse, and the perverse. Semin Radiat Oncol 2002;12(3):272–281.

    Article  PubMed  Google Scholar 

  9. Brady LW. Mesothelioma—the role for radiation therapy. Semin Oncol 1981;8(3):329–334.

    PubMed  CAS  Google Scholar 

  10. Richart R, Sherman CD. Prolonged survival in diffuse pleural mesothelioma treated with Au198. Cancer 1959;12:799.

    Article  PubMed  CAS  Google Scholar 

  11. Law MR, et al. Malignant mesothelioma of the pleura: a study of 52 treated and 64 untreated patients. Thorax 1984;39(4):255–259.

    Article  PubMed  CAS  Google Scholar 

  12. Ball DL, Cruickshank DG. The treatment of malignant mesothelioma of the pleura: review of a 5-year experience, with special reference to radiotherapy. Am J Clin Oncol 1990;13(1):4–9.

    PubMed  CAS  Google Scholar 

  13. Ruffie P, et al. Diffuse malignant mesothelioma of the pleura in Ontario and Quebec: a retrospective study of 332 patients. J Clin Oncol 1989;7(8):1157–1168.

    PubMed  CAS  Google Scholar 

  14. Alberts AS, et al. Malignant pleural mesothelioma: a disease unaffected by current therapeutic maneuvers. J Clin Oncol 1988;6(3):527–535.

    PubMed  CAS  Google Scholar 

  15. Holsti LR, et al. Altered fractionation of hemithorax irradiation for pleural mesothelioma and failure patterns after treatment. Acta Oncol 1997;36(4):397–405.

    PubMed  CAS  Google Scholar 

  16. Mattson K, et al. Multimodality treatment programs for malignant pleural mesothelioma using high-dose hemithorax irradiation. Int J Radiat Oncol Biol Phys 1992;24(4):643–650.

    PubMed  CAS  Google Scholar 

  17. Linden CJ, et al. Effect of hemithorax irradiation alone or combined with doxorubicin and cyclophosphamide in 47 pleural mesotheliomas: a nonrandomized phase II study. Eur Respir J 1996;9(12):2565–2572.

    Article  PubMed  CAS  Google Scholar 

  18. Herscher LL, et al. Phase I study of paclitaxel as a radiation sensitizer in the treatment of mesothelioma and non-small-cell lung cancer. J Clin Oncol 1998;16(2):635–641.

    PubMed  CAS  Google Scholar 

  19. Chen Y, et al. Schedule-dependent pulsed paclitaxel radiosensitization for thoracic malignancy. Am J Clin Oncol 2001;24(5):432–437.

    Article  PubMed  CAS  Google Scholar 

  20. Kindler H, Vogelzang N. Mesothelioma. In: Vokes E, Golomb H, eds. Oncologic Therapies. Berlin: Springer-Verlag, 1999:635–651.

    Google Scholar 

  21. Sugarbaker DJ, et al. Extrapleural pneumonectomy in the multimodality therapy of malignant pleural mesothelioma. Results in 120 consecutive patients. Ann Surg 1996;224(3):288–294; discussion 294–296.

    Article  PubMed  CAS  Google Scholar 

  22. Rusch VW, et al. A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma. J Thorac Cardiovasc Surg 2001;122(4):788–795.

    Article  PubMed  CAS  Google Scholar 

  23. Lee TT, et al. Radical pleurectomy/decortication and intraoperative radiotherapy followed by conformal radiation with or without chemotherapy for malignant pleural mesothelioma. J Thorac Cardiovasc Surg 2002;124(6):1183–1189.

    Article  PubMed  Google Scholar 

  24. Ahamad A, et al. 100% local control of malignant pleural mesothelioma after extrapleural pneumonectomy followed by intensity modulated radiotherapy (IMRT) to the chest. Int J Radiat Oncol Biol Phys 2003;in press.

    Google Scholar 

  25. Forster KM, et al. Intensity-modulated radiation therapy following extrapleural pneumonectomy for the treatment of malignant mesothelioma: clinical implementation. Int J Radiat Oncol Biol Phys 2003;in press.

    Google Scholar 

  26. Boutin C, Rey F, Viallat JR. Prevention of malignant seeding after invasive diagnostic procedures in patients with pleural mesothelioma. A randomized trial of local radiotherapy. Chest 1995;108(3):754–758.

    PubMed  CAS  Google Scholar 

  27. Law MR, Hodson ME, Turner-Warwick M. Malignant mesothelioma of the pleura: clinical aspects and symptomatic treatment. Eur J Respir Dis 1984;65(3):162–168.

    PubMed  CAS  Google Scholar 

  28. Brenner J, et al. Malignant mesothelioma of the pleura: review of 123 patients. Cancer 1982;49(11):2431–2435.

    Article  PubMed  CAS  Google Scholar 

  29. Adams VI, Unni KK. Diffuse malignant mesothelioma of pleura: diagnostic criteria based on an autopsy study. Am J Clin Pathol 1984;82(1):15–23.

    PubMed  CAS  Google Scholar 

  30. Sterman DH, Kaiser LR, Albelda SM. Advances in the treatment of malignant pleural mesothelioma. Chest 1999;116(2):504–520.

    Article  PubMed  CAS  Google Scholar 

  31. de Graaf-Strukowska L, et al. Factors influencing the outcome of radiotherapy in malignant mesothelioma of the pleura—a single-institution experience with 189 patients. Int J Radiat Oncol Biol Phys 1999;43(3):511–516.

    Article  PubMed  Google Scholar 

  32. Gordon W Jr, et al. Radiation therapy in the management of patients with mesothelioma. Int J Radiat Oncol Biol Phys 1982;8(1):19–25.

    PubMed  Google Scholar 

  33. Davis SR, Tan L, Ball DL. Radiotherapy in the treatment of malignant mesothelioma of the pleura, with special reference to its use in palliation. Australas Radiol 1994;38(3):212–214.

    PubMed  CAS  Google Scholar 

  34. Brenner J, et al. Malignant peritoneal mesothelioma: review of 25 patients. Am J Gastroenterol 1981;75(4):311–313.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, University of Pittsburgh Cancer Center, Pittsburgh, PA, USA

    Ryan P. Smith MD

  2. Department of Radiation Oncology, University of Pennsylvania Health System, Philadelphia, PA, USA

    Stephen M. Hahn MD

Authors
  1. Ryan P. Smith MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Stephen M. Hahn MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Thoracic Oncology, Barbara Ann Karmanos Cancer Institute, Harper University Hospital, USA

    Harvey I. Pass MD (Chief and Professor of Surgery and Oncology) (Chief and Professor of Surgery and Oncology)

  2. Wayne State University School of Medicine, Detroit, MI, 48201, USA

    Harvey I. Pass MD (Chief and Professor of Surgery and Oncology) (Chief and Professor of Surgery and Oncology)

  3. Nevada Cancer Institute, USA

    Nicholas J. Vogelzang MD (Director and Clinical Professor) (Director and Clinical Professor)

  4. Department of Internal Medicine, University of Nevada School of Medicine, Las Vegas, NV, 81935, USA

    Nicholas J. Vogelzang MD (Director and Clinical Professor) (Director and Clinical Professor)

  5. Thoracic Oncology, Cardinal Bernardin Cancer Center, Loyola University Chicago, Stritch School of Medicine, Maywood, IL, 60153, USA

    Michele Carbone MD, PhD (Professor of Pathology, Director) (Professor of Pathology, Director)

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer Science+Business Media, Inc.

About this chapter

Cite this chapter

Smith, R.P., Hahn, S.M. (2005). Treatment of Mesothelioma with Radiotherapy. In: Pass, H.I., Vogelzang, N.J., Carbone, M. (eds) Malignant Mesothelioma. Springer, New York, NY. https://doi.org/10.1007/0-387-28274-2_41

Download citation

  • DOI: https://doi.org/10.1007/0-387-28274-2_41

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-22949-2

  • Online ISBN: 978-0-387-28274-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation